0001209191-18-042143.txt : 20180710
0001209191-18-042143.hdr.sgml : 20180710
20180710161414
ACCESSION NUMBER: 0001209191-18-042143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180706
FILED AS OF DATE: 20180710
DATE AS OF CHANGE: 20180710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALLAHUE KIERAN
CENTRAL INDEX KEY: 0001308428
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31161
FILM NUMBER: 18947106
MAIL ADDRESS:
STREET 1: 7530 DRAPER AVENUE
STREET 2: SUITE 6
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER NAME:
FORMER CONFORMED NAME: Gallahue Kieran
DATE OF NAME CHANGE: 20041110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001080709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232908305
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-453-7200
MAIL ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-06
0
0001080709
ARENA PHARMACEUTICALS INC
ARNA
0001308428
GALLAHUE KIERAN
6154 NANCY RIDGE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2018-07-06
4
A
0
1674
0.00
A
1674
D
Common Stock
2018-07-06
4
A
0
3070
0.00
A
4744
D
Stock Option (right to buy)
44.79
2018-07-06
4
A
0
2500
0.00
A
2025-07-06
Common Stock
2500
2500
D
Stock Option (right to buy)
44.79
2018-07-06
4
A
0
4583
0.00
A
2025-07-06
Common Stock
4583
4583
D
The amount represents restricted stock units that vest in three equal installments on the dates of Arena's next three annual meetings of stockholders. The shares underlying the restricted stock units will be issued upon vesting of the restricted stock units.
The amount represents restricted stock units that vest in full on the earliest of June 13, 2019, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting of the restricted stock units.
The options vest in 36 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over three years beginning on August 6, 2018, and are exercisable once vested.
The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on August 6, 2018, and are exercisable once vested.
/s/ Steven W. Spector, as Attorney-in-Fact
2018-07-10
EX-24.4_800895
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of Andrew J. Cronauer or
his successor, Kevin R. Lind or his successor, Steven W. Spector or his
successor, Veronica Vallejo or her successor, and each of them acting singly, as
the true and lawful attorney-in-fact of the undersigned to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an employee, officer and/or director (or pending employee, officer and/or
director) of Arena Pharmaceuticals, Inc. (the "Company"), Form IDs and Forms 3,
4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form ID, 3, 4, or
5, complete and execute any amendment or amendments thereto, and file such form
with the United States Securities and Exchange Commission and any stock exchange
or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in fact on behalf of the
undersigned pursuant to this power of attorney (this "Power of Attorney") shall
be in such form and shall contain such terms and conditions as such attorney in
fact may approve in such attorney in fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this Power of Attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys in fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company, attention the foregoing attorneys in fact.
This Power of Attorney supersedes any previous power of attorney granted by the
undersigned, in the undersigned's capacity as an employee, officer and/or
director of the Company, and relating to Form ID, 3, 4, or 5.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 23rd day of April 2018.
/s/ Kieran T. Gallahue
Signature
Kieran T. Gallahue
Print Name